Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. - Wikidata - awgldk - TriplyDB

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

http://www.wikidata.org/entity/Q38336408

about

The effect of TLR9 agonist CpG oligodeoxynucleotides on the intestinal immune response of cobia (Rachycentron canadum).Conditional immortalization of human B cells by CD40 ligation.Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes Systematic CpT (ApG) depletion and CpG excess are unique genomic signatures of large DNA viruses infecting invertebrates.Spontaneous production of immunoglobulin M in human epithelial cancer cells Potential capacity of aptamers to trigger immune activation in human blood.In vitro test system for evaluation of immune activation potential of new single-stranded DNA-based therapeutics.Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9.CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.TLR9 in health and disease.Development of TLR9 agonists for cancer therapy TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways.Toll-like receptor 9-dependent activation of myeloid dendritic cells by Deoxynucleic acids from Candida albicans.Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.Imprinted DC mediate the immune-educating effect of early-life microbial exposure.Extended sequence preferences for oligodeoxyribonucleotide activity.Toll-Like Receptors and Tissue Remodeling: The Pro/Cons Recent Findings.The effects of CpG-ODNs and Chitosan adjuvants on the elicitation of immune responses induced by the HIV-1-Tat-based candidate vaccines in mice.Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers.Oligodeoxynucleotides inhibit Toll-like receptor 3 mediated cytotoxicity and CXCL8 release in keratinocytes.VaccineDA: Prediction, design and genome-wide screening of oligodeoxynucleotide-based vaccine adjuvants.Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes.Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context.Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.Suppression of Th1- and Th2-type immune responses in infant mouse spleen after prenatal and postnatal exposure to low-level toluene and peptidoglycan.Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.Targeting Myeloid-Derived Suppressor Cells in Cancer.Therapeutic Targeting of Long Non-Coding RNAs in Cancer.Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.Anti-miRNA oligonucleotides: A comprehensive guide for design.Bacterial DNA containing methylated CpG motifs retains immunostimulatory activity in synergy with modified lipopolysaccharides.Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.

P2860

Q31171481-FB472D2A-9FC8-40DA-A766-9A6D3854134A Q33316020-E1F11E47-0736-40C3-821D-2BF154ED0F72 Q33815085-61518AE0-372E-400A-A7F4-3F7A9C5B24B4 Q34450614-6A0CC22D-22BF-4E85-A895-3B50626A0EC5 Q34516619-B11B0692-62EA-46E9-B20C-5142A75BF6D5 Q34918601-2A90CCB0-E8AE-452A-AD62-957AD5C152D8 Q35166708-B759CA34-C316-46A1-B35B-5E8098206954 Q36068780-97C8C0FB-D047-4C34-9C8D-A5F27AB5ACB4 Q36150499-C071316E-706C-4283-B07F-819C10B36B96 Q36378325-49BFA937-69D7-44BE-9C9E-877826F7246A Q36423215-00873FE8-7182-4B8E-99DF-9F0B5D58FDED Q36512593-CA97DB8F-FEDF-4D50-A38C-E3565F397EAD Q36526346-5B4C187C-D2F2-4542-98E3-E8881559CEA6 Q36809776-623EE5DA-3A5E-42DD-BE7B-D39F56F3EFCB Q36940236-C72CE613-050C-408B-9AE8-D775226D70B8 Q37202398-01A5A5DD-9ECD-48E6-B5AF-D2A83C7B8522 Q37256585-D0977359-369F-4F91-8450-446DE8B117C5 Q37643323-138598FE-BB10-486D-9EB7-CCFBED9AB50B Q37855606-48CBF7C8-B642-4FF9-B174-73A711825D1C Q38314811-9B6ECCAA-98D4-4E7F-9E21-A149B92B9654 Q38561820-E39C03DA-833E-4445-80F9-014D2608FB16 Q38973146-36BF608A-829F-46B5-A864-FDA24ED3CC67 Q39258088-5B256F1F-31D9-4593-845A-9CE33E0287B2 Q39443382-937E9176-A273-4DB7-BF9E-E8FDDF9F225C Q40694695-FFED4543-550B-4E2D-A740-7E9D456B7512 Q42124172-48DF14EE-613B-4E39-BFF0-93FBF18A6FB0 Q42359630-0F141F66-2980-4F4F-A499-D6FA909D2DFB Q45090402-1CB86AF2-7F14-4FF7-99EC-A62D184D3383 Q45914983-799CD059-EC9C-4720-8E7D-691385BD854A Q46990192-59EDA8E4-9024-4BBF-B44D-D2D851F6AA93 Q47765346-5DEA3AC8-67D6-4ACB-B878-01C2FECE4A75 Q49961986-FAA504A2-FDE6-4195-8DEE-9ED6C1CFF4E4 Q51810324-14AAB134-B222-4A0B-8F4C-FA1E1B661CC1 Q52640764-7925DBF3-EAA3-46EC-BDD5-426249EC481F Q53577840-B30591AC-43E2-42CA-9E6E-3B5632FC5050 Q54467599-D5CB8606-BEAF-4B67-96CB-C98A5717FAAA

P2860

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

http://www.wikidata.org/entity/Q38336408

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Oligodeoxynucleotides lacking ...... e 2 biased immune stimulation.

@en

type

label

Oligodeoxynucleotides lacking ...... e 2 biased immune stimulation.

@en

prefLabel

Oligodeoxynucleotides lacking ...... e 2 biased immune stimulation.

@en

P1433

Q38336408-36FE335E-8C95-4CBA-B053-C6A7A12BD6E3

P1476

Q38336408-696E1FC2-2D47-4D67-98A5-1668D8A6D619

P2093

Q38336408-14802FA3-A791-475B-8596-00C8A98CD92A

Q38336408-1E82BD06-323B-42FA-968A-8572EC29F297

Q38336408-2C6D2017-449A-4D28-B74B-1AF90B7160AA

Q38336408-4948FD09-8D0E-4CEF-8F51-E6DC8A9DC5CC

Q38336408-6936815B-ABFF-47C6-8C04-EBE1095D3FEF

Q38336408-6DBC784B-2A34-4FAB-9D8B-C168F488E80A

Q38336408-783637F9-28BD-4F77-BE4F-4FBD8D7915E7

Q38336408-C70BABCC-C879-4BA6-A322-B75CADA15646

Q38336408-DA5DF1AC-BF1F-4727-81DF-8F229F62720B

P2860

Q38336408-032F5E58-64B9-4E2A-A090-65490D01D6A6

Q38336408-05CE7D6C-7AC6-4599-AF0D-C47A53F9D97E

Q38336408-071C39CB-49E1-4B86-B6AB-A732E1E303E2

Q38336408-0E50F0E1-C276-4A28-8514-4B79128FF2F5

Q38336408-1A52CE50-555B-419A-90C6-6AE2B007E000

Q38336408-1EE51AEF-A448-4DD8-8CDD-F474D5DBBC14

Q38336408-3775FD70-813F-4A12-A8AE-E0F572301D31

Q38336408-49765AC7-21E4-41BE-82D6-BFA6FCE0F054

Q38336408-60F021C0-A2C5-4CD3-8B18-1F6E3936CB13

Q38336408-65D3ACA1-0088-4876-AD58-14A32B0EADA4

P304

Q38336408-8CE70755-1824-4EAC-8E4B-B7F5786D35BD

P31

Q38336408-F83D19B9-B9D8-418B-B211-7E65A20C8A4A

P356

Q38336408-9C2CC290-4843-4927-ABD9-B21D2C5CB497

P433

Q38336408-8A4D2226-1030-40A4-9CFF-8CAC7CBA5ECC

P478

Q38336408-98337624-C624-4BF9-A4E2-976546304A18

P577

Q38336408-33B9607D-46BD-4F6C-A33A-C34D221FAAB0

P5875

Q38336408-62830E5B-8DD7-478D-81CC-41E404FABB9C

P698

Q38336408-D38FB071-3EDC-4780-BB2A-8C35B9843647

P921

Q38336408-92147110-B312-4856-8D8F-DEFD7AD67E4A

P932

Q38336408-3AFC98F2-5A68-471C-8B2B-08869A6EF11A

P356

J.1365-2567.2004.01962.X

P1433

P1476

Oligodeoxynucleotides lacking ...... e 2 biased immune stimulation.

@en

P2093

Arthur M Krieg

http://www.w3.org/2001/XMLSchema#string

Christian Schetter

http://www.w3.org/2001/XMLSchema#string

Heather L Davis

http://www.w3.org/2001/XMLSchema#string

Jörg Vollmer

http://www.w3.org/2001/XMLSchema#string

Marion Jurk

http://www.w3.org/2001/XMLSchema#string

Michael J McCluskie

http://www.w3.org/2001/XMLSchema#string

Paul Payette

http://www.w3.org/2001/XMLSchema#string

Risini D Weeratna

http://www.w3.org/2001/XMLSchema#string

Ulrike Samulowitz

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

A toll-like receptor that prevents infection by uropathogenic bacteria

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

CpG motifs in bacterial DNA trigger direct B-cell activation.

P304

212-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2567.2004.01962.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8334898

http://www.w3.org/2001/XMLSchema#string

P698

15379982

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

1782571

http://www.w3.org/2001/XMLSchema#string